RWJBarnabas Health - Monmouth Medical Center

Clinical research site in Long Branch, New Jersey

Part of RWJBarnabas Health

As of July 2026, 6 paid clinical trials are recruiting at RWJBarnabas Health - Monmouth Medical Center in Long Branch, New Jersey. Active studies at this site cover conditions such as Cardiac Toxicity, Colon Cancer and Early-stage Breast Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 19, 2026.

Recruiting clinical trials at RWJBarnabas Health - Monmouth Medical Center (6)

Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast Cancer

for HER2-positive Early-stage Breast Cancer

7 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18 - 90

Code: NCT07402473·Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

ATATcH Alternating Treatment Plans for Advanced Cancer

for Head and Neck Cancer

11 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05358548·Phase 2·Recruiting·Listed May 2022

Apply to this trial

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

for Hormone Receptor-Positive Breast Cancer

7 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT06518837·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)

for Gastro-Intestinal Cancer

6 locations incl. Hamilton

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05332002·Phase 2·Recruiting·Listed Apr 2022

Apply to this trial

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

for Cardiac Toxicity

10 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: Female·Age: 18+

Code: NCT05559164·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer

for Colon Cancer

9 locations incl. Elizabeth

Sponsor: Rutgers, The State University of New Jersey

Sex: All·Age: 18+

Code: NCT05806931·Phase 2·Recruiting·Listed Apr 2023

Apply to this trial

More research sites in Long Branch

Monmouth Medical Center (29 trials)
Monmouth Community Medical (1 trial)
Rutgers Cancer Institute of NJ (Rutgers, The State University of New Jersey) (1 trial)

Explore more

Paid clinical trials in Long Branch, NJ · New Jersey clinical trials